Agilent Technologies IncChange company Symbol lookupSelect an option...A Agilent Technologies IncBOF BranchOut Food IncVINO Gaucho Group Holdings IncONVO Organovo Holdings IncZBRA Zebra Technologies CorpBROG Brooge Energy LtdNTZ Natuzzi SpAGE General Electric CoOST Ostin Technology Group Co LtdCHEA Chenghe Acquisition CoGo
Change company Symbol lookup
Select an option...
A Agilent Technologies Inc
BOF BranchOut Food Inc
VINO Gaucho Group Holdings Inc
ONVO Organovo Holdings Inc
ZBRA Zebra Technologies Corp
BROG Brooge Energy Ltd
NTZ Natuzzi SpA
GE General Electric Co
OST Ostin Technology Group Co Ltd
CHEA Chenghe Acquisition Co
Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profileAgilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services, and consumables for the entire laboratory workflow. The Company's life sciences and applied markets segment provides application-focused solutions, which include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab segment offers services portfolio, which consists of repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and various other custom services to support the customers' laboratory operations.
|
|
|
|
| |
| Latest Earnings Met Consensus (Q3 ending 07/2023) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q3 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced August 15, 2023 | $1.43 | Q3 Estimate range of 15 analysts | $1.35 to $1.38 | Q4 Earnings will announce | (Unconfirmed) November 20, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
A's fiscal year ends in October
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.